by Riley Nolan | Feb 17, 2021 | Featured, News
PROVIDENCE, RI, February 17, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) today announces its participation in the INDIGO consortium – a partnership of public and private research and development organizations from the EU, India, and United States (funded by the...
by Annie De Groot | Oct 2, 2020 | Thinking Out Loud -Blog
Generic PANDAmonium I have been hanging out with an old dog – eight year old Jack, during the COVID lockdown. If you are a dog during COVID-19, long walks, lots of snuggles on the couch during Zoom meetings, what’s not to like? Hence the theme of my latest...
by Annie De Groot | Jul 24, 2020 | News, Thinking Out Loud -Blog
Are we “Checking the Box” or Making Vaccines that work? We need a COVID-19 vaccine! From China to the US to Europe and even Africa, scientists are working tirelessly, if not at “warp speed”, to develop and test more than one COVID-19...
by Annie De Groot | Mar 4, 2020 | Featured, News
PROVIDENCE, R.I., Mar. 4, 2020 – EpiVax Inc., a Rhode Island company, announces a collaboration to develop a novel coronavirus SARS-CoV-2 (COVID-19) vaccine with University of Georgia (UGA, Athens GA) vaccine expert Ted Ross (Director, Center for Vaccines and...
by Annie De Groot | Feb 28, 2020 | Events
The 2020 meeting for the National Foundation for Infectious Diseases is taking place at the The Omni Shoreham Hotel in Washington DC, from March 23-25. During the meeting, EpiVax will be represented by Dr. Lenny Moise, director of Vaccines, Dr. Lauren Meyers, of the...